Default Category
-
Pfizer and AstraZeneca: Marketing an Acquisition (B)
Quelch, John A.; Weber, JamesCase HBS-515008-EMarketingThis (B) case provides a brief description of the outcome of the (A) case.Starting at €5.74
-
Pfizer and AstraZeneca: Marketing an Acquisition (A)
Quelch, John A.; Weber, JamesCase HBS-515007-EMarketingIn 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to the challenges of developing new drugs. Over the previous decade or more, Pfizer had pursued acquisitions as a way to acquire new drugs, increase sales, and to reduce costs by comb...Starting at €8.20